Esyalabs is a startup based in the United Kingdom.
Esyalabs develops patented intracellular multi-omics analytics using DNA nanoprobes, proteomics, and AI to enable early diagnosis and precision medicine for neurodegenerative diseases such as Alzheimer's and Parkinson's.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.